Nanoform Finland Oyj Registered Shares o.N.
- BID
0.835
- ASK
0.859
- 2,040 Units289 Units
- 07/24, 21:58:50 PM
Sector and Industry
Healthcare, Healthcare Services
Performance (1Y)
22.83%
Market Cap
-
P/E Ratio
0.00
Dividend Yield
0.00 %
Earnings per Share
-0.21 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| UnitedHealth Group Inc. | 254.66 Bil. | 396.73 Bil. | 24.94 | -19.75 % | 0.00 | - |
| Thermo Fisher Scientific Inc. | 185.62 Bil. | 39.50 Bil. | 32.67 | +1.45 % | 0.00 | - |
| Danaher Corp. | 137.79 Bil. | 21.78 Bil. | 45.36 | -11.47 % | 0.00 | - |
| McKesson Corporation | 90.13 Bil. | 348.09 Bil. | 22.55 | +33.83 % | 0.00 | - |
| HCA Healthcare Inc. | 89.28 Bil. | 67.01 Bil. | 16.48 | +12.93 % | 0.00 | - |
| Elevance Health Inc. | 65.88 Bil. | 176.51 Bil. | 13.91 | -9.22 % | 0.00 | - |
| The Cigna Group | 61.74 Bil. | 243.65 Bil. | 12.41 | +66.33 % | 0.00 | - |
| Cencora Inc. | 51.58 Bil. | 291.15 Bil. | 39.26 | +1.16 % | 0.00 | - |
| IDEXX Laboratories Inc. | 45.92 Bil. | 3.81 Bil. | 51.74 | +14.41 % | 0.00 | - |
| Zoetis Inc. | 45.52 Bil. | 8.39 Bil. | 20.89 | +3.10 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 0.835 G | 0 Units |
| PRICE DETERMINATION TIME | 07/24/2026 / 09:56:41 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 0.838 | 0.78 |
| PREV. DAY'S PRICE | 0.814 | (07/23) |
| CHANGE DAY BEFORE | +0.02 | 2.58 % |
| 52 WEEK HIGH / LOW | 1.27 (10/02) | 0.385 (03/31) |
Key Figures (in EUR)
| 2023 | 2024 | 2025 | 2026e | 2027e | |
|---|---|---|---|---|---|
EARNINGS PER SHARE | -0.26 | -0.28 | -0.21 | -0.14 | -0.11 |
DIVIDENDS PER SHARE | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
DIVIDEND YIELD IN % | 0.00 % | 0.00 % | 0.00 % | - | - |
DIVIDEND GROWTH IN % | - | - | - | - | - |
PRICE - EARNINGS RATIO | - | - | - | - | - |
PRICE - BOOK RATIO | 1.86 | 1.98 | 2.34 | - | - |
PRICE - SALES RATIO | 48.43 | 41.71 | 28.25 | - | - |
PRICE - CASH FLOW RATIO | - | - | - | - | - |
Master Data
| WKN | A2P5N7 |
| ISIN | FI4000330972 |
| SYMBOL | 4YL |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | NANOFORM FINLAND OYJ |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | - |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Healthcare Services |
| NUMBER OF SHARES | - |
| MARKET CAPITALISATION | - |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | 5.30 % | 0.36 % | 72.70 % | -9.83 % | -22.83 % | -50.59 % | -88.02 % | -25.18 % |
| HIGH | 0.87 | 0.87 | 1.10 | 1.10 | 1.27 | 3.18 | 8.17 | 1.21 |
| LOW | 0.78 | 0.74 | 0.46 | 0.39 | 0.39 | 0.39 | 0.39 | 0.39 |
Dividende
pro Aktie
NANOFORM FINLAND OYJ does not deliver dividend information
Company profile
Nanoform Finland Oyj engages in providing expert services in nanotechnology and drug particle engineering for the international pharma industry. It operates through the geographical segments Europe, United States and Others . The company was founded by Edward Hæggström, Kai Falck, Jouko Yliruusi, and Ilkka Aleksi Lassila in 2015 and is headquartered in Helsinki, Finland.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.